Active Ingredient: HEXAFLUORENIUM BROMIDE
Proprietary Name: MYLAXEN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: 20MG/ML
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: N009789
Product Number: 003
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: MEDPOINTE PHARMACEUTICALS MEDPOINTE HEALTHCARE INC
Marketing Status:
Discontinued
Patent and Exclusivity Information